Procysbi (cysteamine bitartrate) — United Healthcare
nephropathic cystinosis
Initial criteria
- Diagnosis of nephropathic cystinosis
Reauthorization criteria
- Documentation of positive clinical response to Procysbi therapy
Approval duration
12 months
nephropathic cystinosis
12 months